Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?


OverviewForecastRevenueFinancialsChartTranscripts

Emergent BioSolutions Ownership Summary


Emergent BioSolutions is owned by 11.39% institutional investors, 2.68% insiders, and 85.94% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.00% of EBS shares. Avantis US Small Cap Value ETF is the top mutual fund, with 3.86% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEmergent BioSolutions11.39%2.68%85.94%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de4.25M8.00%$52.58M
Blackrock3.84M7.36%$26.18M
Vanguard group3.55M6.68%$43.93M
Oak hill advisors lp3.61M6.67%$16.57M
Millennium management2.50M4.60%$12.16M
State street2.45M4.51%$21.57M
American century companies2.38M4.40%$21.01M
Dimensional fund advisors lp2.25M4.23%$27.84M
Palisade capital management, lp1.43M2.63%$12.58M
Charles schwab investment management1.38M2.55%$12.19M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Oak hill advisors lp3.61M3.45%$16.57M
Values first advisors305.05K1.96%$3.77M
Kent lake capital300.00K0.92%$2.05M
Prescott group capital management772.77K0.89%$9.55M
Morse asset management229.31K0.57%$2.83M
Globeflex capital l p241.30K0.46%$2.98M
Palumbo wealth management117.12K0.36%$1.45M
Palisade capital management, lp1.43M0.34%$12.58M
Stirlingshire investments21.11K0.23%$260.92K
Advantage alpha capital partners lp45.94K0.12%$405.16K

Top Buyers

HolderShares% AssetsChange
Millennium management2.50M0.01%1.02M
State street2.45M0.00%705.00K
Morgan stanley1.16M0.00%628.82K
Jain global508.71K0.02%508.71K
Whitebox advisors500.00K0.10%500.00K

Top Sellers

HolderShares% AssetsChange
Blackrock3.84M0.00%-3.22M
Avidity partners management lp---1.91M
Aqr capital management460.31K0.00%-591.39K
Carronade capital management, lp---550.60K
Pacer advisors---536.65K

New Positions

HolderShares% AssetsChangeValue
Whitebox advisors500.00K0.10%500.00K$3.41M
Hrt financial lp311.78K0.01%311.78K$3.85M
Kent lake capital300.00K0.92%300.00K$2.05M
Ritholtz wealth management108.92K0.02%108.92K$1.35M
Segall bryant & hamill80.85K0.01%80.85K$713.09K

Sold Out

HolderChange
National bank of canada /fi/-1.00
Frazier financial advisors-2.00
Federation des caisses desjardins du quebec-4.00
Financial gravity asset management-9.00
Mcf advisors-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202546-74.73%6,057,668-85.48%110.19%26-69.41%7-87.27%
Sep 30, 202568-61.14%10,191,249-74.33%180.35%28-72.28%19-47.22%
Jun 30, 20251723.61%39,625,9449.49%731.65%10012.36%35-12.50%
Mar 31, 20254-97.58%3,665,317-89.44%60.16%1-98.77%2-94.87%
Dec 31, 20241606.67%34,658,9219.38%651.83%7821.88%38-24.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Avantis US Small Cap Value ETF2.01M3.86%-
Vanguard Total Stock Mkt Idx Inv1.61M3.09%-
Vanguard US Total Market Shares ETF1.64M3.01%-
State Street® SPDR® S&P® Biotech ETF1.53M2.93%-8.22K
iShares Russell 2000 ETF1.28M2.46%194.38K
Schwab Fundamental U.S. Small CompanyETF992.13K1.90%-692.00
SPDR® S&P Biotech ETF949.18K1.78%2.12K
Invesco FTSE RAFI US 1500 Small-Mid ETF917.91K1.69%-
Palisade Small Cap Core Equity860.94K1.65%-60.52K
Vanguard Institutional Extnd Mkt Idx Tr565.47K1.09%2.48K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2025Richard Ronald-Sell$177.09K
Dec 05, 2025Richard Ronald-Sell$85.99K
Nov 10, 2025DeGolyer Donald W-Sell$187.62K
Nov 07, 2025Dayal Sujata Tyagi-Sell$85.52K
Oct 07, 2025Glessner Coleen EVP, Quality & Ethics, and CPLSell$306.08K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4-5
2025 Q3-2
2025 Q211
2025 Q1-2

EBS Ownership FAQ


Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 11.39%, followed by 2.68% insiders and 85.93% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Emergent BioSolutions falls below.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock funding, inc. /de (4.25M shares, 8.00%), Blackrock (3.84M shares, 7.36%), and Vanguard group (3.55M shares, 6.68%). Together, they hold 22.03% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Oak hill advisors lp is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 3.45% of its assets in 3.61M Emergent BioSolutions shares, valued at 16.57M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Avantis US Small Cap Value ETF is the top mutual fund holder of Emergent BioSolutions shares, with 3.86% of its total shares outstanding invested in 2.01M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools